QRM Capital

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

Healium is a technology company that develops mental fitness tools and immersive, bio-data-driven experiences to support self-management of anxiety, sleep issues, burnout, and overall well-being. The platform links real-time biometric data from wearables such as heart rate and brain activity via EEG headbands to personalized video or VR assets, producing reactive media escapes controlled by the user’s physiology. By integrating wearable devices and sensors, Healium delivers data-driven content that adapts to the user in real time, aiming to reduce anxiety, improve mood, and build resilience for individuals and organizations. Peer-reviewed studies have reported rapid mood benefits and anxiety reduction in as little as four minutes.

Peptyde Bio is an Agtech startup focused on combating fungal diseases through innovative bio-fungicidal technology. The company specializes in developing natural antimicrobial peptides (AMPs) sourced from plants, which offer a cost-effective and efficient alternative for treating such diseases. By leveraging these natural compounds, Peptyde Bio aims to establish itself as a leading supplier of AMPs, providing effective solutions for agricultural challenges while promoting sustainable practices in crop protection.

Plastomics Inc. is a biotechnology company that specializes in chloroplast genetic engineering to enhance crop performance and nutritional quality. Founded in 2016 and based in Saint Louis, Missouri, the company utilizes a proprietary technology platform to insert beneficial traits into the chloroplasts of plant cells. This innovative approach allows seed companies to develop advanced biotech crops with a diverse array of traits while addressing current industry challenges. Plastomics' technology not only eliminates cross-pollination but also facilitates unique maternal inheritance, significantly reducing breeding timelines and associated costs. By focusing on gene stacking and rapid breeding, Plastomics aims to improve yield production and contribute to the advancement of agricultural biotechnology.